MV
Manu Vanaerschot
Roche Diagnostics, Chan Zuckerberg Biohub, Columbia University - Fidock lab
Research areas: Medicine · Public Health, Environmental and Occupational Health · Research on Leishmaniasis Studies · Trypanosoma species research and implications · Leprosy Research and Treatment
0000-0002-9141-2347
Employment
-
Roche Diagnostics Research Leader, Infectious Diseases2022 - Present
-
Chan Zuckerberg Biohub Scientist II2020 - 2022
-
Columbia University - Fidock lab Associate Research Scientist2017 - 2019
-
Columbia University - Fidock Lab Postdoctoral Research Scientist2015 - 2017
-
Institute of Tropical Medicine Postdoctoral Research Scientist2012 - 2015
-
Institute of Tropical Medicine PhD student2007 - 2011
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (58)
- Evidence of multiple bacterial, viral, and parasitic infectious disease agents in Mastomys natalensis rodents in riverine areas in selected parts of Zambia. Save
- Systematic in vitro evolution in Plasmodium falciparum reveals key determinants of drug resistance. Save
- Investigation of acute encephalitis syndrome with implementation of metagenomic next generation sequencing in Nepal. Save
- Building up a genomic surveillance platform for SARS-CoV-2 in the middle of a pandemic: a true North-South collaboration. Save
- Workshop-based learning and networking: a scalable model for research capacity strengthening in low- and middle-income countries Save
- Luna Virus and Helminths in Wild Mastomys natalensis in Two Contrasting Habitats in Zambia: Risk Factors and Evidence of Virus Dissemination in Semen. Save
- Metagenomic Pathogen Sequencing in Resource-Scarce Settings: Lessons Learned and the Road Ahead. Save
- Genomic Epidemiology and Transmission Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Congregate Healthcare Facilities in Santa Clara County, California. Save
- Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention Save
- The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance. Save
- Whole Genome Sequence Analysis to Identify SARS-CoV-2 Variant in Nepal. Save
- Estimation of secondary household attack rates for emergent spike L452R SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco. Save
- The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957. Save
- Identification of a Polymorphism in the N Gene of SARS-CoV-2 That Adversely Impacts Detection by Reverse Transcription-PCR. Save
- Rapid deployment of SARS-CoV-2 testing: The CLIAHUB. Save
- Evaluation of whole genome amplification and bioinformatic methods for the characterization of Leishmania genomes at a single cell level. Save
- Identification of a polymorphism in the N gene of SARS-CoV-2 that adversely impacts detection by a widely-used RT-PCR assay Save
- Complete Genome Sequence of a Novel Coronavirus (SARS-CoV-2) Isolate from Bangladesh. Save
- Inhibition of resistance-refractory P. falciparum kinase PKG delivers prophylactic, blood stage, and transmission-blocking antiplasmodial activity Save
- Probing the Open Global Health Chemical Diversity Library for multistage-active starting points for next-generation antimalarials. Save